It is a monoclonal antibody against the IL-6 receptor.
Any drug ending in -mab is a monoclonal antibody and there are hundreds either on the market or in the Big Pharma pipeline undergoing clinical trials
I was wrong! Oh no. I am sorry.
It is a humanized MAB. Thank you for the corrections.
I did that. Worked one through clinical trials while employed by a big pharma.
Made mabs. But mine were chimera, not humanized.
And I am retired now from the bench...so probably falling behind..
Thanks again. First time I have heard of an MAB
labeled a receptor antagonist.